CLOCK gene T3111C polymorphism is associated with Japanese schizophrenics: a preliminary study.

Department of Psychiatry, Medical Sciences for Control of Pathological Processes, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Ibaraki, Japan.
European Neuropsychopharmacology (Impact Factor: 5.4). 04/2007; 17(4):273-6. DOI: 10.1016/j.euroneuro.2006.09.002
Source: PubMed

ABSTRACT The CLOCK gene has attracted attention due to its influence on the circadian rhythm, as well as its impacts on the dopaminergic system. We conducted a preliminary study to examine whether the T3111C single nucleotide polymorphism of the CLOCK gene is associated with the development of schizophrenia by examining samples from schizophrenics (n=145) and normal controls (n=128). Both genotype and allele frequencies were significantly different between schizophrenics and controls (p=0.022, p=0.015, respectively). Schizophrenics had a significantly higher frequency of the C allele compared to controls (odds ratio 1.76, 95% CI 1.12-2.75). In particular, disorganized and residual type schizophrenics had significantly higher C allele frequencies than controls (p=0.004 and p=0.037, respectively). Our results suggest that the T3111C polymorphism of the CLOCK gene is associated with schizophrenia. It is important to explore the association between CLOCK and dopamine function, and to examine the impact of CLOCK on phenotypes such as symptoms and drug response in patients with schizophrenia.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective: Despite the high prevalence of sleep disturbances in patients with co-occurring schizophrenia and substance use disorders, very little is known about sleep in this population. This paper reviews the existing literature on sleep in patients with schizophrenia and substance use disorders. Methods: PubMed and Ovid searches were performed using combinations of the terms “sleep,” “schizophrenia,” and names of commonly abused individual substances. Since searches regarding sleep in patients with dual diagnoses returned few results, we also explored the sleep abnormalities inherent in schizophrenia and in substance use disorders separately. Results: Our search identified 1,667 papers and 111 were included for review. We summarized what little is known about primary sleep disorders in this population and identified commonalities in sleep disturbances in each disease with emphasis on underlying pathophysiology as well as the effects of antipsychotics. Conclusions: Given the high prevalence of sleep abnormalities in patients with schizophrenia and substance use disorders, the relative paucity of clinical guidance, and the potential impact that sleep disorders can have on the course of disease, there is a need for additional research regarding sleep in patients with co-occurring schizophrenia and substance use disorders to improve recognition and management of these comorbid conditions.
    Journal of Dual Diagnosis 08/2013; 9(3):228-238. DOI:10.1080/15504263.2013.806088 · 0.80 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background The arginine vasopressin receptor (AVPR) and oxytocin receptor (OXTR) genes have been demonstrated to contribute to prosocial behavior. Recent research has focused on the manner by which these simple receptor genes influence prosociality, particularly with regard to the AVP system, which is modulated by the clock gene. The clock gene is responsible for regulating the human biological clock, affecting sleep, emotion and behavior. The current study examined in detail whether the influences of the OXTR and AVPR1b genes on prosociality are dependent on the clock gene. Methodology/Principal Findings This study assessed interactions between the clock gene (rs1801260, rs6832769) and the OXTR (rs1042778, rs237887) and AVPR1b (rs28373064) genes in association with individual differences in prosociality in healthy male Chinese subjects (n = 436). The Prosocial Tendencies Measure (PTM-R) was used to assess prosociality. Participants carrying both the GG/GA variant of AVPR1b rs28373064 and the AA variant of clock rs6832769 showed the highest scores on the Emotional PTM. Carriers of both the T allele of OXTR rs1042778 and the C allele of clock rs1801260 showed the lowest total PTM scores compared with the other groups. Conclusions The observed interaction effects provide converging evidence that the clock gene and OXT/AVP systems are intertwined and contribute to human prosociality.
    PLoS ONE 10/2014; 9(10):e109086. DOI:10.1371/journal.pone.0109086 · 3.53 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Sleep disturbance is common in several epilepsy types, such as juvenile myoclonic epilepsy (JME). Genetic background could increase susceptibility to seizure and sleep abnormalities. From this perspective, a susceptibility gene for sleep disturbance or chronotype could contribute to the genetic susceptibility threshold for epilepsy and vice versa. Accordingly, we investigated whether functional clock gene polymorphisms (PER2 111C>G, CLOCK 3111T>C, and PER3 VNTR) might influence the risk for JME. All these polymorphisms have recently been reported to be associated with sleep disturbance, diurnal variation, and neurological diseases. The polymorphisms were genotyped in 97 patients and 212 controls using polymerase chain reaction or restriction fragment length polymorphism methods. No significant differences were observed in the genotypic and allelic frequencies of these polymorphisms between cases and controls even when analyses were restricted to patients that presented a diurnal preferential seizure occurrence. We also tested for interactions between polymorphisms by multifactor dimensionality reduction analysis. None of the combined genotypes differed significantly between the groups. These results present no evidence for an association of these polymorphisms with JME. Further studies including other types of epilepsy and/or other functional polymorphisms are required to investigate the possible relationship between clock genes and the genetic susceptibility to chronic seizure.
    Epilepsy & Behavior 05/2014; 36C:82-85. DOI:10.1016/j.yebeh.2014.04.024 · 2.06 Impact Factor